search
Back to results

Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis (PULPISOLONE)

Primary Purpose

Pulpitis

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Partial endodontic treatment under local and/or locoregional anesthesia
prednisolone
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pulpitis focused on measuring Anesthesia, Corticosteroids, Dental Emergency, Irreversible Pulpitis, Mandibulae, Pain Management, Partial Endodontic Treatment

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinical signs of irreversible pulpitis on a mandibular molar,
  • ASA1 or ASA2 score (American Society of Anesthesiologists)
  • Age between 18 and 70 years (of either gender)
  • Ability to give written informed consent
  • Affiliation to a health insurance scheme
  • Agreement to be contacted by phone 24h after the emergency visit
  • Availability to come back 72 hours after the emergency visit for endodontic treatment

Exclusion Criteria:

  • Diagnosis of reversible pulpitis, acute apical periodontitis, periodontal lesion of endodontic origin or dentin syndrome
  • Not retainable tooth requiring extraction
  • Contraindication of endodontic treatment (endocarditis risk) or local anaesthesia
  • Contraindication for the prescription of glucocorticoids, paracetamol or codeine,
  • Oral infection, viral disease in evolution (hepatitis, herpes zoster, .. ),
  • Machine operators ,
  • Psychosis uncontrolled by treatment, or chronic consumption of drugs or alcohol
  • Allergy to one or more of the components,
  • Diabetes, drug intake with direct interaction with glucocorticoids, paracetamol or codeine,
  • Woman of child-bearing age without contraceptive, pregnancy, breastfeeding
  • Not able to give informed consent,
  • Participating in another interventional study

Sites / Locations

  • CHU de Bordeaux

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control

Experimental

Arm Description

Outcomes

Primary Outcome Measures

Pain intensity on a numeric scale

Secondary Outcome Measures

The number of antalgic drugs taken after the emergency visit
The number of patients coming back to consultation at 72h
The number of injected anesthetic cartridges when performing the endodontic treatment
Patient's comfort evaluation during the endodontic treatment using a questionnaire with numeric scales

Full Information

First Posted
December 7, 2015
Last Updated
December 19, 2018
Sponsor
University Hospital, Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT02629042
Brief Title
Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis
Acronym
PULPISOLONE
Official Title
Efficacy of Oral Prednisolone Versus Partial Endodontic Treatment on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis of Mandibular Molars: Non Inferiority Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2018
Overall Recruitment Status
Completed
Study Start Date
May 15, 2017 (Actual)
Primary Completion Date
November 28, 2018 (Actual)
Study Completion Date
December 3, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Bordeaux

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Irreversible pulpitis is an inflammatory condition of the dental pulp, highly painful, representing one of the main reasons for consulting dental emergency. The recommended emergency care is a partial endodontic treatment under local and/or locoregional anesthesia. The purpose of the emergency partial endodontic treatment is to stop the pain of pulpitis by removing a portion of the pulp. The final endodontic treatment is ideally performed 72 hours after. The literature reports major difficulty in obtaining adequate anesthesia in the mandible to perform partial endodontic treatment, especially for the mandibular molars. This results in a very painful care for the patient. The management of this type of emergency is costly in terms of equipment and time for health facilities. Patient comfort, cost saving and rationalization of the care time justify the search for an alternative to emergency partial endodontic treatment. In current practice, the short course oral corticotherapy is used in the management of oral pain from inflammatory origin. Glucocorticoids, thanks to their anti-inflammatory action, can neutralize the inflammatory mediators and thus pain. The pulp inflammation can be treated with this molecule: the effectiveness of intraosseous local steroid injection for irreversible pulpitis of mandibular molars has already been shown but results in local comorbidities and requires specific device. Oral administration of short-course prednisolone is simple and safe but its effectiveness to manage pain caused by irreversible pulpitis has not yet been demonstrated. Per-os administration of prednisolone has a very high (90%) and rapid (≤ 4 hours) bioavailability. No difference in effectiveness between intravenous and oral administration of this molecule was reported. This oral treatment could limit comorbidities and technical difficulties related to intraosseous injection and could delay the endodontic treatment to 72 hours in optimal conditions of anesthesia for the patient. Despite the difficulties described for the partial endodontic treatment, it is very effective in pain reduction and can reach 100% of success. Therefore a non-inferiority design was chosen to compare the effect of a short-course oral corticotherapy to a partial endodontic treatment for the reduction of pain at the emergency care of the irreversible pulpitis in mandibular molars. The intervention arm will receive an oral dose of prednisolone (1 mg/kg) during the emergency visit followed-up by one morning dose by day during three days and the reference arm will have partial endodontic treatment. Both groups will have planned complete endodontic treatment 72 hours after enrolment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulpitis
Keywords
Anesthesia, Corticosteroids, Dental Emergency, Irreversible Pulpitis, Mandibulae, Pain Management, Partial Endodontic Treatment

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
5 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
Active Comparator
Arm Title
Experimental
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Partial endodontic treatment under local and/or locoregional anesthesia
Intervention Description
The reference management consists in local and locoregional anesthesia of the molar and partial endodontic treatment. At the end of the emergency visit, all the patients, whatever their randomization group, will be given two types of antalgics and will be recommended to take them only if they have pain. Seventy-two hours after, all the patients, whatever their randomization will have endodontic treatment under local and locoregional anesthesia.
Intervention Type
Drug
Intervention Name(s)
prednisolone
Intervention Description
The evaluated intervention consists in per-os administration of prednisolone (1 mg / kg) during the emergency visit followed-up by one morning dose by day during three days. At the end of the emergency visit, all the patients, whatever their randomization group, will be given two types of antalgics and will be recommended to take them only if they have pain. Seventy-two hours after, all the patients, whatever their randomization will have endodontic treatment under local and locoregional anesthesia.
Primary Outcome Measure Information:
Title
Pain intensity on a numeric scale
Time Frame
24 hours after the emergency visit (inclusion)
Secondary Outcome Measure Information:
Title
The number of antalgic drugs taken after the emergency visit
Time Frame
72 hours after the emergency visit (inclusion)
Title
The number of patients coming back to consultation at 72h
Time Frame
72 hours after the emergency visit (inclusion)
Title
The number of injected anesthetic cartridges when performing the endodontic treatment
Time Frame
72 hours after the emergency visit (inclusion)
Title
Patient's comfort evaluation during the endodontic treatment using a questionnaire with numeric scales
Time Frame
72 hours after the emergency visit (inclusion)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical signs of irreversible pulpitis on a mandibular molar, ASA1 or ASA2 score (American Society of Anesthesiologists) Age between 18 and 70 years (of either gender) Ability to give written informed consent Affiliation to a health insurance scheme Agreement to be contacted by phone 24h after the emergency visit Availability to come back 72 hours after the emergency visit for endodontic treatment Exclusion Criteria: Diagnosis of reversible pulpitis, acute apical periodontitis, periodontal lesion of endodontic origin or dentin syndrome Not retainable tooth requiring extraction Contraindication of endodontic treatment (endocarditis risk) or local anaesthesia Contraindication for the prescription of glucocorticoids, paracetamol or codeine, Oral infection, viral disease in evolution (hepatitis, herpes zoster, .. ), Machine operators , Psychosis uncontrolled by treatment, or chronic consumption of drugs or alcohol Allergy to one or more of the components, Diabetes, drug intake with direct interaction with glucocorticoids, paracetamol or codeine, Woman of child-bearing age without contraceptive, pregnancy, breastfeeding Not able to give informed consent, Participating in another interventional study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elise ARRIVE
Organizational Affiliation
USMR, CHU de Bordeaux
Official's Role
Study Chair
Facility Information:
Facility Name
CHU de Bordeaux
City
Bordeaux
ZIP/Postal Code
33000
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
28351379
Citation
Kerouredan O, Jallon L, Perez P, Germain C, Peli JF, Oriez D, Fricain JC, Arrive E, Devillard R. Efficacy of orally administered prednisolone versus partial endodontic treatment on pain reduction in emergency care of acute irreversible pulpitis of mandibular molars: study protocol for a randomized controlled trial. Trials. 2017 Mar 28;18(1):141. doi: 10.1186/s13063-017-1883-x.
Results Reference
derived

Learn more about this trial

Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis

We'll reach out to this number within 24 hrs